U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06937931) titled 'A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults' on April 14.
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of the study drug, IPN10200, and to assess how well it works when compared with placebo in treating Cervical Dystonia (CD) in adults.
CD can cause a series of abnormalities and symptoms in the head and neck that can lead to neck pain and stiffness, and headaches. CD is believed to involve deep parts within the brain that control movement, but genetic factors, environmental factors, and abnormalities in the brain may also play a role.
The usual treatment for CD includes ...